Description

2,598,400 equity shares of Hemant Surgical Industries Limited issued on preferential basis to non-promoters listed and permitted to trade on BSE.

Summary

BSE has listed 2,598,400 new equity shares of Hemant Surgical Industries Limited (Scrip Code: 543916) issued on a preferential basis to non-promoters. The shares are permitted to trade from November 7, 2025. The shares were allotted at Rs. 197/- per share (face value Rs. 10/- with premium of Rs. 187/-) on September 18, 2025, and are subject to lock-in periods extending through May 2026.

Key Points

  • 2,598,400 equity shares of Rs. 10/- each issued at premium of Rs. 187/-
  • Issue price: Rs. 197/- per share
  • Issued to non-promoters on preferential basis
  • Shares rank pari-passu with existing equity shares
  • Distribution numbers: 10440001 to 13038400
  • Date of allotment: September 18, 2025
  • Trading commencement: November 7, 2025
  • ISIN: INE0GYI01028
  • Scrip Code: 543916

Regulatory Changes

No regulatory changes. This is a standard listing notification for preferential allotment.

Compliance Requirements

Trading members must note the listing and lock-in restrictions:

  • 1,049,600 shares (Dist. Nos. 10440001-11489600) locked-in until May 31, 2026
  • 1,548,800 shares (Dist. Nos. 11489601-13038400) locked-in until May 30, 2026

Important Dates

  • Allotment Date: September 18, 2025
  • Trading Commencement: November 7, 2025
  • Lock-in Expiry (Batch 1): May 31, 2026 (1,049,600 shares)
  • Lock-in Expiry (Batch 2): May 30, 2026 (1,548,800 shares)

Impact Assessment

This is a routine preferential allotment listing with minimal market impact. The lock-in periods ensure that the newly issued shares cannot be traded immediately, protecting against sudden supply increases. The preferential issue to non-promoters increases the public float of Hemant Surgical Industries Limited. Trading members should be aware of the lock-in restrictions when processing orders for this scrip.

Impact Justification

Routine preferential allotment listing for a single company with limited market-wide impact